{"id":5461,"date":"2021-03-18T14:01:11","date_gmt":"2021-03-18T14:01:11","guid":{"rendered":"https:\/\/www.neuraxpharm.com\/it2\/?page_id=5461"},"modified":"2023-03-22T12:09:01","modified_gmt":"2023-03-22T12:09:01","slug":"wettelijke-kennisgeving","status":"publish","type":"page","link":"https:\/\/www.neuraxpharm.com\/nl\/wettelijke-kennisgeving","title":{"rendered":"Wettelijke kennisgeving"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"5461\" class=\"elementor elementor-5461\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-1d97ce1f politicas elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"1d97ce1f\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[{&quot;jet_parallax_layout_image&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;_id&quot;:&quot;42d129b&quot;,&quot;jet_parallax_layout_image_tablet&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_image_mobile&quot;:{&quot;url&quot;:&quot;&quot;,&quot;id&quot;:&quot;&quot;,&quot;size&quot;:&quot;&quot;},&quot;jet_parallax_layout_speed&quot;:{&quot;unit&quot;:&quot;%&quot;,&quot;size&quot;:50,&quot;sizes&quot;:[]},&quot;jet_parallax_layout_type&quot;:&quot;scroll&quot;,&quot;jet_parallax_layout_direction&quot;:&quot;1&quot;,&quot;jet_parallax_layout_fx_direction&quot;:null,&quot;jet_parallax_layout_z_index&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x&quot;:50,&quot;jet_parallax_layout_bg_x_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_x_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y&quot;:50,&quot;jet_parallax_layout_bg_y_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_y_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size&quot;:&quot;auto&quot;,&quot;jet_parallax_layout_bg_size_tablet&quot;:&quot;&quot;,&quot;jet_parallax_layout_bg_size_mobile&quot;:&quot;&quot;,&quot;jet_parallax_layout_animation_prop&quot;:&quot;transform&quot;,&quot;jet_parallax_layout_on&quot;:[&quot;desktop&quot;,&quot;tablet&quot;]}]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-778b1f90\" data-id=\"778b1f90\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-d5b98dd elementor-widget elementor-widget-heading\" data-id=\"d5b98dd\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">Wettelijke kennisgeving<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a3bce3b elementor-widget elementor-widget-text-editor\" data-id=\"a3bce3b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Deze website (neuraxpharm.com) is eigendom van NEURAXPHARM HOLDCO IBERIA S.L., waarvan de maatschappelijke zetel gevestigd is te Av. Barcelona, 69, 08970 &#8211; Sant Joan Desp\u00ed (Barcelona &#8211; Spanje), en geregistreerd in het handelsregister van Barcelona in volume 45486, blad 2, pagina n\u00ba B-489.406, met het Spaanse fiscale identificatienummer: B-87459624 en het e-mailadres dpo@neuraxpharm.com.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Wettelijke kennisgeving Deze website (neuraxpharm.com) is eigendom van NEURAXPHARM HOLDCO IBERIA S.L., waarvan de maatschappelijke zetel gevestigd is te Av. Barcelona, 69, 08970 &#8211; Sant Joan Desp\u00ed (Barcelona &#8211; Spanje), en geregistreerd in het handelsregister van Barcelona in volume 45486, blad 2, pagina n\u00ba B-489.406, met het Spaanse fiscale identificatienummer: B-87459624 en het e-mailadres dpo@neuraxpharm.com.<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-5461","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Wettelijke kennisgeving - Neuraxpharm Netherlands<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.neuraxpharm.com\/nl\/wettelijke-kennisgeving\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Wettelijke kennisgeving\" \/>\n<meta property=\"og:description\" content=\"Wettelijke kennisgeving Deze website (neuraxpharm.com) is eigendom van NEURAXPHARM HOLDCO IBERIA S.L., waarvan de maatschappelijke zetel gevestigd is te Av. Barcelona, 69, 08970 &#8211; Sant Joan Desp\u00ed (Barcelona &#8211; Spanje), en geregistreerd in het handelsregister van Barcelona in volume 45486, blad 2, pagina n\u00ba B-489.406, met het Spaanse fiscale identificatienummer: B-87459624 en het e-mailadres dpo@neuraxpharm.com.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.neuraxpharm.com\/nl\/wettelijke-kennisgeving\" \/>\n<meta property=\"og:site_name\" content=\"Neuraxpharm Netherlands\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-22T12:09:01+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.neuraxpharm.com\/nl\/wettelijke-kennisgeving\",\"url\":\"https:\/\/www.neuraxpharm.com\/nl\/wettelijke-kennisgeving\",\"name\":\"Wettelijke kennisgeving - Neuraxpharm Netherlands\",\"isPartOf\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/nl\/#website\"},\"datePublished\":\"2021-03-18T14:01:11+00:00\",\"dateModified\":\"2023-03-22T12:09:01+00:00\",\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.neuraxpharm.com\/nl\/wettelijke-kennisgeving\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.neuraxpharm.com\/nl\/#website\",\"url\":\"https:\/\/www.neuraxpharm.com\/nl\/\",\"name\":\"Neuraxpharm Netherlands\",\"description\":\"Ein europ\u00e4ischer Marktf\u00fchrer f\u00fcr CNS-Produkte\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.neuraxpharm.com\/nl\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Wettelijke kennisgeving - Neuraxpharm Netherlands","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.neuraxpharm.com\/nl\/wettelijke-kennisgeving","og_locale":"nl_NL","og_type":"article","og_title":"Wettelijke kennisgeving","og_description":"Wettelijke kennisgeving Deze website (neuraxpharm.com) is eigendom van NEURAXPHARM HOLDCO IBERIA S.L., waarvan de maatschappelijke zetel gevestigd is te Av. Barcelona, 69, 08970 &#8211; Sant Joan Desp\u00ed (Barcelona &#8211; Spanje), en geregistreerd in het handelsregister van Barcelona in volume 45486, blad 2, pagina n\u00ba B-489.406, met het Spaanse fiscale identificatienummer: B-87459624 en het e-mailadres dpo@neuraxpharm.com.","og_url":"https:\/\/www.neuraxpharm.com\/nl\/wettelijke-kennisgeving","og_site_name":"Neuraxpharm Netherlands","article_modified_time":"2023-03-22T12:09:01+00:00","twitter_card":"summary_large_image","twitter_misc":{"Geschatte leestijd":"1 minuut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.neuraxpharm.com\/nl\/wettelijke-kennisgeving","url":"https:\/\/www.neuraxpharm.com\/nl\/wettelijke-kennisgeving","name":"Wettelijke kennisgeving - Neuraxpharm Netherlands","isPartOf":{"@id":"https:\/\/www.neuraxpharm.com\/nl\/#website"},"datePublished":"2021-03-18T14:01:11+00:00","dateModified":"2023-03-22T12:09:01+00:00","inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.neuraxpharm.com\/nl\/wettelijke-kennisgeving"]}]},{"@type":"WebSite","@id":"https:\/\/www.neuraxpharm.com\/nl\/#website","url":"https:\/\/www.neuraxpharm.com\/nl\/","name":"Neuraxpharm Netherlands","description":"Ein europ\u00e4ischer Marktf\u00fchrer f\u00fcr CNS-Produkte","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.neuraxpharm.com\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.neuraxpharm.com\/nl\/wp-json\/wp\/v2\/pages\/5461","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neuraxpharm.com\/nl\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.neuraxpharm.com\/nl\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/nl\/wp-json\/wp\/v2\/comments?post=5461"}],"version-history":[{"count":41,"href":"https:\/\/www.neuraxpharm.com\/nl\/wp-json\/wp\/v2\/pages\/5461\/revisions"}],"predecessor-version":[{"id":26767,"href":"https:\/\/www.neuraxpharm.com\/nl\/wp-json\/wp\/v2\/pages\/5461\/revisions\/26767"}],"wp:attachment":[{"href":"https:\/\/www.neuraxpharm.com\/nl\/wp-json\/wp\/v2\/media?parent=5461"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}